The Legend Holdings, Kangji Medical and Poly Group-backed surgical robotic arm developer raised the cash in a series C round co-led by Boyu Capital, Temasek and Sequoia Capital China.

Edge Medical Robotics, the China-based robotic surgical technology developer backed by corporates Kangji Medical, Legend Holdings and Poly Group, has secured $200m in series C funding, DealStreetAsia reported yesterday.

Boyu Capital, Temasek and Sequoia Capital China co-led the round, which also featured OrbiMed, Octagon Capital, Sage Partners, Greater Bay Area Homeland Investments, Mirae Asset, Lyfe Capital, 3H Health Investment and Guoce Capital.

Edge Medical provides a range of surgical equipment, including a robotic arm, for use in multi-port laparoscopic surgery.…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn